ICMR study finds Covaxin booster dose improves effectiveness against Delta, Omicron variants Read more
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study Read more
No scientific evidence to support need for booster vaccine dose against COVID, says ICMR chief Read more